Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Araniforce T is a homeopathic medicinal product developed and manufactured by Weber & Weber Biologische Arzneimittel. It is formulated as an oral tablet containing a D4 trituration of *Aranea diadema* (the cross spider). Within the framework of homeopathic therapy, Araniforce T is primarily indicated for the treatment of nerve pain (neuralgia) and rheumatic complaints, particularly those that exhibit sensitivity to cold and damp environments. As a homeopathic preparation, its therapeutic approach is based on the principle of 'like cures like,' intended to stimulate the body's endogenous regulatory and self-healing mechanisms rather than acting through conventional pharmacological receptor-mediated pathways. It is marketed in Germany as a registered homeopathic drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Araniforce T.